Literature DB >> 21733438

Functional outcome of matrix-associated autologous chondrocyte implantation in the ankle.

Sean Dixon1, Leigh Harvey, Edward Baddour, Greg Janes, Gerard Hardisty.   

Abstract

BACKGROUND: The technique of Matrix-associated autologous chondrocyte implantation (MACI) is well established with satisfactory outcomes up to 5 years in the knee. Fewer series describe the outcomes of this technique in the ankle. We present the functional outcomes of the technique for a single surgeon series in a general hospital setting.
MATERIALS AND METHODS: Twenty-seven patients, mean age 41, were reviewed at 3.7 (range, 1 to 5) years. Patients were assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot scale, Tegener activity score and University of California lower extremity activity scale. MRI findings were also reviewed.
RESULTS: While most patients report a significant improvement in symptoms with full return to activities of daily living, 36% of those under 40 and 78% of those over 40 reported restricted recreational activity. Of the patients under 40 years of age, 86% were able to run compared with 23% of those over 40. Of patients over 40, 64% continued to have moderate or severe pain.
CONCLUSION: Careful preoperative counseling is required for patients of all ages regarding likely outcomes. In patients over 40, the procedure is unlikely to give good pain relief and alternative options should be considered.

Entities:  

Mesh:

Year:  2011        PMID: 21733438     DOI: 10.3113/FAI.2011.0368

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

1.  Fibrin glue does not assist migration and proliferation of chondrocytes in collagenic membranes: an in vitro study.

Authors:  Filippo Migliorini; Julia Prinz; Nicola Maffulli; Jörg Eschweiler; Christian Weber; Sophie Lecoutrier; Frank Hildebrand; Johannes Greven; Hanno Schenker
Journal:  J Orthop Surg Res       Date:  2022-06-11       Impact factor: 2.677

2.  High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Ramón Navarro; Rosa Caballero-Santos; Marta Guillén-Vicente; Mercedes Casqueiro; Tomás F Fernández-Jaén; Fernando Sanz; Santiago Arauz; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2019-03-17       Impact factor: 4.634

3.  Scaffolds based therapy for osteochondral lesions of the talus: A systematic review.

Authors:  Yoshiharu Shimozono; Youichi Yasui; Andrew W Ross; Wataru Miyamoto; John G Kennedy
Journal:  World J Orthop       Date:  2017-10-18

4.  Morphological Assessment of MACI Grafts in Patients with Revision Surgery and Total Joint Arthroplasty.

Authors:  Aswin Beck; David Wood; Christopher J Vertullo; Jay Ebert; Greg Janes; Martin Sullivan; Ming-Hao Zheng
Journal:  Cartilage       Date:  2019-12-02       Impact factor: 3.117

5.  Demographics in Patients Receiving Matrix-Assisted Chondrocyte Implantation (MACI) in the Ankle.

Authors:  Kris T C Hede; Andreas H Gomoll; Casper Bindzus Foldager
Journal:  Cartilage       Date:  2019-08-20       Impact factor: 3.117

6.  Autologous Matrix Induced Chondrogenesis (AMIC) Compared to Microfractures for Chondral Defects of the Talar Shoulder: A Five-Year Follow-Up Prospective Cohort Study.

Authors:  Filippo Migliorini; Jörg Eschweiler; Nicola Maffulli; Hanno Schenker; Arne Driessen; Björn Rath; Markus Tingart
Journal:  Life (Basel)       Date:  2021-03-16

7.  AMIC for traumatic focal osteochondral defect of the talar shoulder: a 5 years follow-up prospective cohort study.

Authors:  Christian Götze; Christian Nieder; Hanna Felder; Christian Dominik Peterlein; Filippo Migliorini
Journal:  BMC Musculoskelet Disord       Date:  2021-07-24       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.